Piramal Pharma Limited (BOM:543635)
169.90
-2.40 (-1.39%)
At close: Jan 1, 2026
Piramal Pharma Market Cap
Piramal Pharma has a market cap or net worth of 225.58 billion as of December 31, 2025. Its market cap has decreased by -31.69% in one year.
Market Cap
225.58B
Enterprise Value
266.64B
Revenue
89.36B
Ranking
n/a
PE Ratio
n/a
Stock Price
169.90
Market Cap Chart
Since October 19, 2022, Piramal Pharma's market cap has decreased from 226.73B to 225.58B, a decrease of -0.51%. That is a compound annual growth rate of -0.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 1, 2026 | 225.58B | -1.35% |
| Dec 31, 2025 | 228.67B | -35.22% |
| Dec 31, 2024 | 352.98B | 92.16% |
| Dec 29, 2023 | 183.69B | 34.26% |
| Dec 30, 2022 | 136.81B | -39.66% |
| Oct 19, 2022 | 226.73B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Reliance Industries | 20.92T |
| HDFC Bank | 15.25T |
| Bharti Airtel | 12.51T |
| Tata Consultancy Services | 11.75T |
| ICICI Bank | 9.60T |
| State Bank of India | 8.91T |
| Infosys | 6.56T |
| Bajaj Finance | 6.14T |